US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1016-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1015-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1014-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1013-2020
Class II · Moderate risk Terminated

Regular Strength Acid Reducer

Reason CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Perrigo Company PLC D-1012-2020
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason Presence of Foreign Substance

Mylan Pharmaceuticals Inc. NDC 0378-4003-05 D-0186-2020
Class I · High risk Terminated

Green Lumber Natural Fuel For Men capsule

Reason Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.

Green Lumber Holdings, LLC D-0351-2020
Class II · Moderate risk Terminated

Estradiol Vaginal Inserts USP

Reason Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.

Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-0156-2020
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Presence of Foreign Tablets/Capsules: a single tablet of Pravastatin 40 mg found in bottle of Atorvastatin Calcium 40 mg.

Apotex Inc. NDC 60505-2580-8 D-0153-2020
Class III · Low risk Terminated

PF-Succinylcholine Chloride Injection

Reason Incorrect labeling: Incorrect or missing lot and/or exp date

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-919-10 D-0154-2020
Class II · Moderate risk Terminated

Basic Reset CBD Reset 2400

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0194-2020
Class II · Moderate risk Terminated

Nuovi Firming Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0190-2020
Class II · Moderate risk Terminated

Basic Reset Nuovi Skin Toner

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0189-2020
Class II · Moderate risk Terminated

Miracle Facelift Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0188-2020
Class II · Moderate risk Terminated

Prasugrel Tablets 5 mg

Reason Failed Dissolution Specification: Low out of specification dissolution results.

Mylan Pharmaceuticals Inc. NDC 0378-5185-93 D-0155-2020